About Us

Aaron Bensimon, Ph.D., co-founder, CEO & President

Aaron founded Genomic Vision in 2005 and was appointed as the company’s President and Chief Executive Officer in May 2006. He also serves as Genomic Vision’s Chief Scientific Officer.

Aaron has brought more than 20 years of scientific and management experience to Genomic Vision and is responsible for the overall planning and execution of the company’s operations. He also facilitates and coordinates research collaborations and licensing and business agreements between Genomic Vision and other industry leaders and supervises trademark and patent activities.

Aaron co-discovered Molecular Combing and is a renowned expert on all aspects of this pioneering technology including its applications. His contributions to this field have been published extensively in leading medical and business journals and he has authored more then 20 patent applications that have been granted on Molecular Combing

Prior to Genomic Vision he spent 15 years in a permanent position at the Pasteur Institute in Paris where he was Head of the Genome Stability Unit. Aaron received the Jacques Monod prize from the Fondation de France (an award to young scientists who have made significant advances in the early years of their career). Formerly, he pursued post-doctoral research in Prof. Jean-Pierre Changeux’s laboratory, Pasteur Institute, Paris, where he was awarded a Human Frontier Science Fellowship. Aaron received his Ph.D. from the Weizmann Institute of Science, Israel in 1993.

Daniel Nerson, Ph.D., co-founder

Genomic Vision has sadly lost its co-founder, Daniel Nerson, Ph.D., who passed away unexpectedly on February 21st, 2010

Daniel Nerson co-founded Genomic Vision in 2005 and was COO & Sales-Marketing Director. He was responsible for leading all aspects of Genomic Vision’s commercial functions including strategic marketing and sales planning and communication.

Daniel had a distinguished career in the diagnostics industry, most latterly as the Commercial Director and a member of the Management Board at Pasteur Mediavita (Pasteur Institute spin-off). Previously he worked for 16 years at Dade Behring (today Siemens Healthcare Diagnostics), where he was rapidly promoted for national and European roles in business development, sales and marketing management positions as Strategic Business Unit Director (Europe).

Daniel had an academic background in pharmaceutical sciences and obtained a Ph.D. at the Pasteur Institute in 1986. During his doctoral research he developed a novel diagnostic ELISA test for meningitis. He received specific entrepreneurial training at the HEC, International Business School, Paris, in 2004.

Erwan Martin, M.A., CFO

Prior to joining Genomic Vision in 2009, Erwan Martin was CFO at Cytomics Pharmaceuticals, a Paris-based drug discovery company which he co-founded in 2003 with scientists from CNRS.

Previously he has been a consultant for 10 years at Syndex, a French audit company. Erwan is a graduate of Toulouse Business School (France) and holds an MBA from Warwick Business School (UK).

Emmanuel Conseiller, VP Research & Development

Prior to joining Genomic Vision in 2009, Emmanuel worked for 19 years at sanofi-aventis and its former companies, mostly in the oncology field.

He pioneered functional genomics applied to drug discovery and development (from target identification to clinical trials) and developed several gene therapy and drug discovery projects in the fields of tumor suppression, DNA replication and tumor metabolism.